Samuel Peña-Llopis

10PUBLICATIONS
28CO-AUTHORS
Molecular targetsPredictive and prognostic markersChemotherapyMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 22, 2026
Proteogenomic Analysis of HDAC4 and HDAC5 in Uveal Melanoma.

|Jul 28, 2026
Correction: Raab et al. Truncated DAPK Variants Restore Tumor Suppressor Activity and Synergize with Standard Therapies in High-Grade Serous Ovarian Cancer. Cancers 2025, 17, 1910.

|Aug 04, 2025
Autophagy suppression via SRC induction represents a therapeutic vulnerability for BAP1-mutant cancers.

Silvia Vega-Rubin-de-Celis, Amanda Kristani, Matthias Kudla

|Jun 26, 2025
Truncated DAPK Variants Restore Tumor Suppressor Activity and Synergize with Standard Therapies in High-Grade Serous Ovarian Cancer.

Monika Raab, Khayal Gasimli, Balázs Győrffy

|Dec 23, 2023
Rescue of p53 functions by in vitro-transcribed mRNA impedes the growth of high-grade serous ovarian cancer.

Monika Raab, Izabela Kostova, Samuel Peña-Llopis

|Nov 18, 2022
The non-apoptotic function of Caspase-8 in negatively regulating the CDK9-mediated Ser2 phosphorylation of RNA polymerase II in cervical cancer.

Ranadip Mandal, Monika Raab, Franz Rödel

Pageof 2

Frequent Collaborators

5 joint publications

Mourad Sanhaji

4 joint publications

Svenja Mergener

4 joint publications

Klaus Strebhardt

2 joint publications

Ranadip Mandal